Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Quantum Genomics
Biotech
Roivant founder departs for White House bid—Chutes & Ladders
Roivant Sciences founder ditches board for White House bid; FDA oncology leader departs for new biotech; Medidata names new execs.
Max Bayer
,
Gabrielle Masson
Feb 24, 2023 9:30am
Fallout from Quantum Genomics' phase 3 fail claims executives
Feb 22, 2023 2:06pm
Quantum's high-stakes hypertension phase 3 fails, tanking stock
Oct 28, 2022 8:55am
Quantum Genomics’ blood pressure drug beats phase 2
Nov 12, 2018 4:24pm